tooluniverse-drug-repurposing
Drug Repurposing with ToolUniverse
Systematically identify and evaluate drug repurposing candidates using multiple computational strategies.
IMPORTANT: Always use English terms in tool calls (drug names, disease names, target names), even if the user writes in another language. Only try original-language terms as a fallback if English returns no results. Respond in the user's language.
Core Strategies
1. Target-Based Repurposing
Start with disease targets → Find drugs that modulate those targets
2. Compound-Based Repurposing
Start with approved drugs → Find new disease indications
3. Disease-Driven Repurposing
Start with disease → Find targets → Match to existing drugs
Quick Start
from tooluniverse import ToolUniverse
tu = ToolUniverse(use_cache=True)
tu.load_tools()
# Example: Find repurposing candidates for a disease
disease_name = "rheumatoid arthritis"
# Step 1: Get disease information
disease_info = tu.tools.OpenTargets_get_disease_id_description_by_name(
diseaseName=disease_name
)
# Step 2: Get associated targets
disease_id = disease_info['data']['id']
targets = tu.tools.OpenTargets_get_associated_targets_by_disease_efoId(
efoId=disease_id,
limit=10
)
# Step 3: Find drugs for each target
for target in targets['data'][:5]:
drugs = tu.tools.DGIdb_get_drug_gene_interactions(
gene_name=target['gene_symbol']
)
# Evaluate each drug candidate...
Complete Workflow
Phase 1: Disease & Target Analysis
# 1.1 Get disease information
disease_info = tu.tools.OpenTargets_get_disease_id_description_by_name(
diseaseName="[disease_name]"
)
# 1.2 Find associated targets
targets = tu.tools.OpenTargets_get_associated_targets_by_disease_efoId(
efoId=disease_info['data']['id'],
limit=20
)
# 1.3 Get target details for top candidates
target_details = []
for target in targets['data'][:10]:
details = tu.tools.UniProt_get_entry_by_accession(
accession=target['uniprot_id']
)
target_details.append(details)
Phase 2: Drug Discovery
# 2.1 Find drugs targeting disease-associated targets
drug_candidates = []
for target in targets['data'][:10]:
# Search DrugBank
drugbank_results = tu.tools.drugbank_get_drug_name_and_description_by_target_name(
target_name=target['gene_symbol']
)
# Search DGIdb
dgidb_results = tu.tools.DGIdb_get_drug_gene_interactions(
gene_name=target['gene_symbol']
)
# Search ChEMBL
chembl_results = tu.tools.ChEMBL_search_drugs(
query=target['gene_symbol'],
limit=10
)
drug_candidates.extend([drugbank_results, dgidb_results, chembl_results])
# 2.2 Get drug details
for drug_name in unique_drugs:
# Get DrugBank info
drug_info = tu.tools.drugbank_get_drug_basic_info_by_drug_name_or_id(
drug_name_or_drugbank_id=drug_name
)
# Get current indications
indications = tu.tools.drugbank_get_indications_by_drug_name_or_drugbank_id(
drug_name_or_drugbank_id=drug_name
)
# Get pharmacology
pharmacology = tu.tools.drugbank_get_pharmacology_by_drug_name_or_drugbank_id(
drug_name_or_drugbank_id=drug_name
)
Phase 3: Safety & Feasibility Assessment
# 3.1 Check FDA safety data
for drug in top_candidates:
# Get warnings and precautions
warnings = tu.tools.FDA_get_warnings_and_cautions_by_drug_name(
drug_name=drug['name']
)
# Get adverse event reports
adverse_events = tu.tools.FAERS_search_reports_by_drug_and_reaction(
drug_name=drug['name'],
limit=100
)
# Get drug interactions
interactions = tu.tools.drugbank_get_drug_interactions_by_drug_name_or_id(
drug_name_or_id=drug['name']
)
# 3.2 Assess ADMET properties (for novel formulations)
for drug in top_candidates:
if 'smiles' in drug:
admet = tu.tools.ADMETAI_predict_admet(
smiles=drug['smiles'],
use_cache=True
)
Phase 4: Literature Evidence
# 4.1 Search for existing evidence
for drug in top_candidates:
# PubMed search
query = f"{drug['name']} AND {disease_name}"
pubmed_results = tu.tools.PubMed_search_articles(
query=query,
max_results=50
)
# Europe PMC search
pmc_results = tu.tools.EuropePMC_search_articles(
query=query,
limit=50
)
# Clinical trials
trials = tu.tools.ClinicalTrials_search(
condition=disease_name,
intervention=drug['name']
)
Phase 5: Scoring & Ranking
Create a scoring function to rank candidates:
def score_repurposing_candidate(drug, target_score, safety_data, literature_count):
"""Score drug repurposing candidate (0-100)."""
score = 0
# Target association strength (0-40 points)
score += min(target_score * 40, 40)
# Safety profile (0-30 points)
if drug['approval_status'] == 'approved':
score += 20
elif drug['approval_status'] == 'clinical':
score += 10
if not safety_data.get('black_box_warning'):
score += 10
# Literature evidence (0-20 points)
score += min(literature_count / 5 * 20, 20)
# Drug-likeness (0-10 points)
if drug.get('bioavailability') == 'high':
score += 10
return score
# Score all candidates
scored_candidates = []
for drug in drug_candidates:
score = score_repurposing_candidate(
drug=drug,
target_score=drug['target_association_score'],
safety_data=drug['safety_profile'],
literature_count=drug['supporting_papers']
)
drug['repurposing_score'] = score
scored_candidates.append(drug)
# Sort by score
ranked_candidates = sorted(
scored_candidates,
key=lambda x: x['repurposing_score'],
reverse=True
)
Alternative Strategies
Strategy A: Mechanism-Based Repurposing
# Find drugs with similar mechanism of action
known_drug = "metformin"
# Get mechanism
moa = tu.tools.drugbank_get_drug_desc_pharmacology_by_moa(
mechanism_of_action="[moa_term]"
)
# Get similar drugs
similar = tu.tools.ChEMBL_search_similar_molecules(
query=known_drug,
similarity_threshold=70
)
Strategy B: Network-Based Repurposing
# Use pathway analysis
pathways = tu.tools.drugbank_get_pathways_reactions_by_drug_or_id(
drug_name_or_drugbank_id="[drug_name]"
)
# Find drugs affecting same pathways
pathway_drugs = tu.tools.drugbank_get_drug_name_and_description_by_pathway_name(
pathway_name=pathways['data'][0]['pathway_name']
)
Strategy C: Phenotype-Based Repurposing
# Search by indication/phenotype
indication_drugs = tu.tools.drugbank_get_drug_name_and_description_by_indication(
indication="[related_indication]"
)
# Analyze adverse events as therapeutic effects
# Example: minoxidil (hypertension) → hair growth
adverse_as_therapeutic = tu.tools.FAERS_search_reports_by_drug_and_reaction(
drug_name="[drug_name]",
limit=1000
)
Key ToolUniverse Tools
Disease & Target Tools:
OpenTargets_get_disease_id_description_by_name- Disease lookupOpenTargets_get_associated_targets_by_disease_efoId- Disease targetsUniProt_get_entry_by_accession- Protein details
Drug Discovery Tools:
drugbank_get_drug_name_and_description_by_target_name- Drugs by targetdrugbank_get_drug_name_and_description_by_indication- Drugs by indicationDGIdb_get_drug_gene_interactions- Drug-gene interactionsChEMBL_search_drugs- Drug searchChEMBL_get_drug_mechanisms- Mechanism of action
Drug Information Tools:
drugbank_get_drug_basic_info_by_drug_name_or_id- Basic drug infodrugbank_get_indications_by_drug_name_or_drugbank_id- Approved indicationsdrugbank_get_pharmacology_by_drug_name_or_drugbank_id- Pharmacologydrugbank_get_targets_by_drug_name_or_drugbank_id- Drug targets
Safety Assessment Tools:
FDA_get_warnings_and_cautions_by_drug_name- FDA warningsFAERS_search_reports_by_drug_and_reaction- Adverse eventsFAERS_count_death_related_by_drug- Serious outcomesdrugbank_get_drug_interactions_by_drug_name_or_id- Interactions
Property Prediction Tools:
ADMETAI_predict_admet- ADMET propertiesADMETAI_predict_toxicity- Toxicity prediction
Literature Tools:
PubMed_search_articles- PubMed searchEuropePMC_search_articles- Europe PMC searchClinicalTrials_search- Clinical trials
Output Format
Present results as ranked candidates:
## Drug Repurposing Analysis: [Disease Name]
### Top 10 Repurposing Candidates
#### 1. [Drug Name] (Score: 87/100)
**Current Indications**: [list approved uses]
**Proposed Indication**: [new disease/condition]
**Repurposing Rationale**: Targets [gene/protein] with high association to disease
**Evidence Summary**:
- Target association score: 0.85
- Approval status: FDA approved (safer profile)
- Literature support: 23 papers, 4 clinical trials
- Safety profile: No black box warnings
**Mechanism**: [Brief mechanism description]
**Next Steps**:
- Phase II trial feasibility assessment
- Patient population identification
- Dosing optimization study
**Key Papers**:
1. Smith et al. 2024 - Clinical efficacy in similar condition
2. Jones et al. 2023 - Mechanism validation
---
#### 2. [Drug Name] (Score: 79/100)
[Similar structure...]
### Supporting Analysis
**Target Network**: [visualization or description]
**Pathway Overlap**: [affected pathways]
**Safety Considerations**: [major concerns]
**Development Timeline**: [estimated phases]
Scoring Criteria
Target Association (0-40 points):
- Strong genetic evidence: 40
- Moderate association: 25
- Pathway-level evidence: 15
- Weak/predicted: 5
Safety Profile (0-30 points):
- FDA approved: 20
- Phase III: 15
- Phase II: 10
- Phase I: 5
- No black box warning: +10
- Known serious AE: -10
Literature Evidence (0-20 points):
- Clinical trials: 5 points each (max 15)
- Preclinical studies: 1 point each (max 10)
- Case reports: 0.5 points each (max 5)
Drug Properties (0-10 points):
- High bioavailability: 5
- Good BBB penetration (if CNS): 5
- Low toxicity predictions: 5
Best Practices
- Start Broad: Query multiple databases (DrugBank, ChEMBL, DGIdb)
- Validate Targets: Confirm target-disease associations in OpenTargets
- Check Safety First: Prioritize approved drugs with known safety profiles
- Literature Mining: Always search for existing clinical/preclinical evidence
- Use Caching: Enable
use_cache=Truefor expensive predictions - Batch Operations: Use
tu.run_batch()for parallel queries - Consider Mechanism: Evaluate biological plausibility
- Patent Landscape: Check if indication is already protected
- Market Analysis: Consider unmet medical need and commercial viability
- Regulatory Path: FDA approved drugs have faster repurposing path
Common Patterns
Pattern 1: Rapid Screening
# Quick screening of 100+ drugs against disease targets
targets = get_disease_targets(disease_id)[:10]
all_drugs = []
for target in targets:
drugs = tu.tools.DGIdb_get_drug_gene_interactions(
gene_name=target['gene_symbol']
)
all_drugs.extend(drugs)
# Filter to FDA approved only
approved_drugs = [d for d in all_drugs if d.get('approved')]
Pattern 2: Deep Dive Single Drug
# Comprehensive analysis of one drug candidate
drug_name = "metformin"
# Get everything
info = tu.tools.drugbank_get_drug_basic_info_by_drug_name_or_id(drug_name_or_drugbank_id=drug_name)
targets = tu.tools.drugbank_get_targets_by_drug_name_or_drugbank_id(drug_name_or_drugbank_id=drug_name)
indications = tu.tools.drugbank_get_indications_by_drug_name_or_drugbank_id(drug_name_or_drugbank_id=drug_name)
pharmacology = tu.tools.drugbank_get_pharmacology_by_drug_name_or_drugbank_id(drug_name_or_drugbank_id=drug_name)
interactions = tu.tools.drugbank_get_drug_interactions_by_drug_name_or_id(drug_name_or_id=drug_name)
warnings = tu.tools.FDA_get_warnings_and_cautions_by_drug_name(drug_name=drug_name)
papers = tu.tools.PubMed_search_articles(query=f"{drug_name} AND [new_disease]", max_results=100)
Pattern 3: Comparative Analysis
# Compare multiple candidates side-by-side
candidates = ["drug_a", "drug_b", "drug_c"]
comparison = []
for drug in candidates:
data = {
'name': drug,
'info': tu.tools.drugbank_get_drug_basic_info_by_drug_name_or_id(drug_name_or_drugbank_id=drug),
'safety': tu.tools.FDA_get_warnings_and_cautions_by_drug_name(drug_name=drug),
'evidence': tu.tools.PubMed_search_articles(query=drug, max_results=10)
}
comparison.append(data)
Troubleshooting
"Disease not found":
- Try disease synonyms or EFO ID lookup
- Use broader disease categories
"No drugs found for target":
- Check target name/symbol (HUGO nomenclature)
- Expand to pathway-level drugs
- Consider similar targets (protein family)
"Insufficient literature evidence":
- Search for drug class rather than specific drug
- Check preclinical/animal studies
- Look for mechanism papers
"Safety data unavailable":
- Drug may not be FDA approved in US
- Check EMA or other regulatory databases
- Review clinical trial safety data
Example Use Cases
Use Case 1: Find repurposing candidates for rare disease
# Rare disease often lack approved drugs
# Strategy: Find drugs targeting same pathways as related common diseases
rare_disease = "Niemann-Pick disease"
related_disease = "Alzheimer's disease" # Similar pathology
# Get pathways affected in related disease
targets = tu.tools.OpenTargets_get_associated_targets_by_disease_efoId(
efoId=related_disease_id
)
# Find drugs for those targets
# Evaluate for rare disease applicability
Use Case 2: Repurpose based on adverse effects
# Adverse effect in one context = therapeutic in another
# Example: Thalidomide (teratogenic) → cancer treatment
drug = "drug_name"
adverse_events = tu.tools.FAERS_search_reports_by_drug_and_reaction(
drug_name=drug,
limit=1000
)
# Analyze if adverse effects beneficial in other contexts
# Example: weight loss AE → obesity treatment potential
Use Case 3: Combination therapy discovery
# Find drugs that complement existing therapy
primary_drug = "existing_therapy"
disease = "disease_name"
# Get targets not covered by primary drug
disease_targets = tu.tools.OpenTargets_get_associated_targets_by_disease_efoId(
efoId=disease_id
)
primary_targets = tu.tools.drugbank_get_targets_by_drug_name_or_drugbank_id(
drug_name_or_drugbank_id=primary_drug
)
# Find drugs for uncovered targets
uncovered_targets = [t for t in disease_targets if t not in primary_targets]
Advanced Techniques
Technique 1: Polypharmacology-Based Repurposing
# Find drugs with multi-target activity matching disease network
# Get disease network
targets = tu.tools.OpenTargets_get_associated_targets_by_disease_efoId(
efoId=disease_id,
limit=50
)
# For each drug, count how many disease targets it hits
for drug in candidate_drugs:
drug_targets = tu.tools.drugbank_get_targets_by_drug_name_or_drugbank_id(
drug_name_or_drugbank_id=drug
)
overlap = len(set(drug_targets) & set(disease_targets))
if overlap >= 3: # Multi-target match
print(f"{drug}: hits {overlap} disease targets")
Technique 2: Structure-Based Repurposing
# Find structurally similar approved drugs
known_active = "known_active_compound"
# Get structure
cid = tu.tools.PubChem_get_CID_by_compound_name(
compound_name=known_active
)
# Find similar
similar = tu.tools.PubChem_search_compounds_by_similarity(
cid=cid['data']['cid'],
threshold=85
)
# Check which are approved drugs
for compound in similar['data']:
drug_info = tu.tools.PubChem_get_drug_label_info_by_CID(
cid=compound['cid']
)
Technique 3: AI-Powered Candidate Selection
# Use ML predictions to filter candidates
candidates_with_smiles = get_candidates_with_structures()
# Predict ADMET for all
admet_results = []
for drug in candidates_with_smiles:
admet = tu.tools.ADMETAI_predict_admet(
smiles=drug['smiles'],
use_cache=True
)
admet_results.append({
'drug': drug['name'],
'admet': admet,
'pass': evaluate_admet_criteria(admet)
})
# Keep only drugs passing ADMET criteria
viable_candidates = [r for r in admet_results if r['pass']]
Resources
For comprehensive disease analysis, see disease-intelligence-gatherer skill.
For compound property analysis, see chemical-compound-retrieval skill.
For detailed ToolUniverse SDK usage, see tooluniverse-sdk skill.
More from wu-yc/labclaw
rowan
Cloud-based quantum chemistry platform with Python API. Preferred for computational chemistry workflows including pKa prediction, geometry optimization, conformer searching, molecular property calculations, protein-ligand docking (AutoDock Vina), and AI protein cofolding (Chai-1, Boltz-1/2). Use when tasks involve quantum chemistry calculations, molecular property prediction, DFT or semiempirical methods, neural network potentials (AIMNet2), protein-ligand binding predictions, or automated computational chemistry pipelines. Provides cloud compute resources with no local setup required.
18tooluniverse-chemical-safety
Comprehensive chemical safety and toxicology assessment integrating ADMET-AI predictions, CTD toxicogenomics, FDA label safety data, DrugBank safety profiles, and STITCH chemical-protein interactions. Performs predictive toxicology (AMES, DILI, LD50, carcinogenicity), organ/system toxicity profiling, chemical-gene-disease relationship mapping, regulatory safety extraction, and environmental hazard assessment. Use when asked about chemical toxicity, drug safety profiling, ADMET properties, environmental health risks, chemical hazard assessment, or toxicogenomic analysis.
18rdkit
Cheminformatics toolkit for fine-grained molecular control. SMILES/SDF parsing, descriptors (MW, LogP, TPSA), fingerprints, substructure search, 2D/3D generation, similarity, reactions. For standard workflows with simpler interface, use datamol (wrapper around RDKit). Use rdkit for advanced control, custom sanitization, specialized algorithms.
17tooluniverse-clinical-guidelines
Search and retrieve clinical practice guidelines across 12+ authoritative sources including NICE, WHO, ADA, AHA/ACC, NCCN, SIGN, CPIC, CMA, CTFPHC, GIN, MAGICapp, PubMed, EuropePMC, TRIP, and OpenAlex. Covers disease management, cardiology, oncology, diabetes, pharmacogenomics, and more. Use when users ask about clinical guidelines, treatment recommendations, standard of care, evidence-based medicine, or drug-gene dosing recommendations.
17tooluniverse-protein-therapeutic-design
Design novel protein therapeutics (binders, enzymes, scaffolds) using AI-guided de novo design. Uses RFdiffusion for backbone generation, ProteinMPNN for sequence design, ESMFold/AlphaFold2 for validation. Use when asked to design protein binders, therapeutic proteins, or engineer protein function.
17tooluniverse-spatial-transcriptomics
Analyze spatial transcriptomics data to map gene expression in tissue architecture. Supports 10x Visium, MERFISH, seqFISH, Slide-seq, and imaging-based platforms. Performs spatial clustering, domain identification, cell-cell proximity analysis, spatial gene expression patterns, tissue architecture mapping, and integration with single-cell data. Use when analyzing spatial transcriptomics datasets, studying tissue organization, identifying spatial expression patterns, mapping cell-cell interactions in tissue context, characterizing tumor microenvironment spatial structure, or integrating spatial and single-cell RNA-seq data for comprehensive tissue analysis.
17